INTS / Intensity Therapeutics, Inc. - Institutionelt ejerskab - Købere

Intensity Therapeutics, Inc.
US ˙ NasdaqCM ˙ US45828J1034

Institutionelt og fondsejerskab - Købere

Større indehavere, der har åbnet nye stillinger i Intensity Therapeutics, Inc., omfatter Geode Capital Management, Llc, Sapient Capital Llc, Nano Cap New Millennium Growth Fund L P, Sentinus, LLC, Vanguard Capital Management Llc, Mesirow Financial Investment Management, Inc., Vanguard Fiduciary Trust Co, Advisor Group Holdings, Inc., Wells Fargo & Company/mn, UBS Group AG, Tower Research Capital LLC (TRC), og Morgan Stanley .

Denne side viser ændringer i ejerskabsstrukturen ved at notere institutioner, fonde og større aktionærer, der har øget deres beholdning eller åbnet nye positioner i den seneste rapporteringsperiode. Grønne rækker angiver nye positioner. Klik på linket ikon for at se den fulde transaktionshistorik.

Opgrader for at låse op for premium-data.

Fil dato Kilde Investor Type Gennemsnitlig pris
(Øst)
Aktier Δ Aktier
(%)
Rapporteret
Værdi
($1000)
Δ Værdi
(%)
Port Alloc
(%)
2026-05-15 13F Tower Research Capital LLC (TRC) 67 0
2026-05-15 13F Nano Cap New Millennium Growth Fund L P 25.000 147
2026-05-05 13F UBS Group AG 192 1
2026-05-15 13F Morgan Stanley 20 0
2026-05-15 13F Geode Capital Management, Llc 26.019 153
2026-05-15 13F Advisor Group Holdings, Inc. 200 1
2026-05-15 13F/A Vanguard Capital Management Llc 16.841 99
2026-05-08 13F Vanguard Fiduciary Trust Co This fund is a listed as child fund of Vanguard Group Inc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value 9.121 54
2026-05-06 13F Sentinus, LLC 23.294 137
2026-04-08 13F Sapient Capital Llc 26.006 153
2026-04-21 13F Mesirow Financial Investment Management, Inc. 14.118 83
2026-05-11 13F Wells Fargo & Company/mn 200 1
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista